Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects
Clinical trial NCT03211234 · COMPLETED
Trial details
- NCT number
- NCT03211234
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2019-12-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.